Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

Overview of attention for article published in Cardiovascular Diabetology, July 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,138 followers.

No IMT changes were observed between the tofogliflozin and the conventional treatment groups. https://t.co/fJ43uhatuS

RT @Office_j: なお、腹囲径、血圧はSGLT2阻害薬群で有意に低下し、HDL-Cは有意に増加。 https://t.co/GwcnzLPGVe

なお、腹囲径、血圧はSGLT2阻害薬群で有意に低下し、HDL-Cは有意に増加。 https://t.co/GwcnzLPGVe

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.